Senseonics Holdings, Inc. — Investor Relations & Filings

Senseonics Holdings, Inc. is a medical technology company focused on the design, development, and commercialization of glucose monitoring products for people with diabetes. The company's primary offering is the Eversense® Continuous Glucose Monitoring (CGM) System, distinguished as the first and only long-term, implantable glucose sensor. The system consists of a sensor inserted subcutaneously, a removable smart transmitter worn over the sensor, and a mobile application for displaying real-time glucose data, trends, and alerts. The Eversense system is designed to provide continuous glucose monitoring for up to six months from a single sensor, aiming to reduce the frequency of sensor insertions compared to traditional CGM systems.